FDA — authorised 27 June 2012
- Application: ANDA201276
- Marketing authorisation holder: MYLAN INSTITUTIONAL
- Local brand name: CIDOFOVIR
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
FDA authorised cidofovir 1% topical ointment on 27 June 2012
Yes. FDA authorised it on 27 June 2012; FDA authorised it on 26 July 2012.
MYLAN INSTITUTIONAL holds the US marketing authorisation.